|
House Bill
|
1237
|
An Act to ensure equitable health coverage for children
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2881
|
An Act enhancing the health care market review process
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
672
|
An Act increasing access to maternal postpartum home visiting services
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Executive Office of Health and Human Services (EOHHS)
|
Discussions and feedback regarding issues including program administration and policies, health coverage, oral health, prescription drugs, mental health, children's health, health care access and affordability, social determinants of health, MassHealth waiver, primary care, private equity, market oversight, and drivers of health care costs including hospital and health system prices and consolidation.
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
740
|
An Act to ensure equitable health coverage for children
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1249
|
An Act relative to reducing administrative burden
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Discussions about health policy including prescription drug costs, health care cost containment, affordability for health care consumers, maternal health, children's health, health coverage and care access, hospital expansions, health equity, consumer costs, the benchmark process, market oversight, private equity, and hospital costs and prices.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1214
|
An Act to promote continuity of health coverage for children
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Center for Health Information and Analysis (CHIA)
|
Discussions on issues related to reports on health care costs, affordability, access to coverage and care, health equity, medical debt, and hospital and health system costs, financial health, and prices.
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
734
|
An Act updating high-cost hospital and Health Policy Commission system accountability
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Discussions and feedback on issues related to private health insurance, including required coverage and benefits, health insurance provider directories, behavioral health, telehealth; health coverage issues; mental health parity, rate review, insurance premiums, and drivers of health care costs including hospital and health system prices.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1143
|
An Act to improve the health insurance prior authorization process
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Commonwealth Health Insurance Connector Authority
|
Discussions about operational and policy issues including health care affordability affecting Health Connector members, especially those with ConnectorCare, health coverage issues and standards, the ConnectorCare expansion pilot, and relevant reports.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
944
|
An Act reining in premiums through stronger rate review
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4891
|
An Act promoting access and affordability of prescription drugs
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1189
|
An Act updating high-cost hospitals and Health Policy Commission system accountability
|
Support
|
$0.00
|
N/A
|
|
Executive
|
MassHealth
|
Discussions and feedback regarding issues including MassHealth eligibility and enrollment issues, MassHealth redeterminations process, oral health, prescription drugs, telehealth, mental health, children's health, health care access for specific populations, social determinants of health, Health Related Social Needs, Flexible Services, implementation of the MassHealth waiver, access to benefits for people with disabilities, provider taxes, and primary care.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
985
|
An Act increasing access to postpartum home visiting services
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4800
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1219
|
An Act enhancing the market review process
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Department of Public Health (DPH)
|
Discussions relative to children's health, maternal health, oral health, vaccines, social determinants of health, and Determination of Need.
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
943
|
An Act to reduce co-pays for people with chronic conditions
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4620
|
An Act enhancing the market review process
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Group Insurance Commission (GIC) (Executive Office for Administration and Finance)
|
Discussion of health policy issues including reducing prescription drugs costs, hospital pricing, cost sharing and affordability for consumers, budget priorities and opportunities for coalition building.
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
5159
|
An Act enhancing the market review process
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
614
|
An Act reining in premiums through stronger rate review
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
3012
|
An Act promoting access and affordability of prescription drugs
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
945
|
An Act to ensure prescription drug cost transparency and affordability
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2871
|
An Act enhancing the health care market review process
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
749
|
An Act relative to pharmaceutical access, costs and transparency
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4643
|
An Act enhancing the market review process
|
Support
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |